| First Author | Koo JW | Year | 2012 |
| Journal | Science | Volume | 338 |
| Issue | 6103 | Pages | 124-8 |
| PubMed ID | 23042896 | Mgi Jnum | J:188256 |
| Mgi Id | MGI:5440098 | Doi | 10.1126/science.1222265 |
| Citation | Koo JW, et al. (2012) BDNF is a negative modulator of morphine action. Science 338(6103):124-8 |
| abstractText | Brain-derived neurotrophic factor (BDNF) is a key positive regulator of neural plasticity, promoting, for example, the actions of stimulant drugs of abuse such as cocaine. We discovered a surprising opposite role for BDNF in countering responses to chronic morphine exposure. The suppression of BDNF in the ventral tegmental area (VTA) enhanced the ability of morphine to increase dopamine (DA) neuron excitability and promote reward. In contrast, optical stimulation of VTA DA terminals in nucleus accumbens (NAc) completely reversed the suppressive effect of BDNF on morphine reward. Furthermore, we identified numerous genes in the NAc, a major target region of VTA DA neurons, whose regulation by BDNF in the context of chronic morphine exposure mediated this counteractive function. These findings provide insight into the molecular basis of morphine-induced neuroadaptations in the brain's reward circuitry. |
